Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

HIV Envelope Trimer Specific Immune Response Is Influenced by Different Adjuvant Formulations and Heterologous Prime-Boost

Full text
Author(s):
Apostolico, Juliana de Souza [1] ; Boscardin, Silvia Beatriz [2] ; Yamamoto, Marcio Massao [2] ; de Oliveira-Filho, Jethe Nunes [1] ; Kalil, Jorge [3, 4] ; Cunha-Neto, Edecio [3, 4, 5] ; Rosa, Daniela Santoro [4, 1]
Total Authors: 7
Affiliation:
[1] Fed Univ Sao Paulo UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo - Brazil
[2] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo - Brazil
[3] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo - Brazil
[4] Inst Invest Immunol INCT, Sao Paulo - Brazil
[5] Univ Sao Paulo, Sch Med, Lab Clin Immunol & Allergy LIM60, Sao Paulo - Brazil
Total Affiliations: 5
Document type: Journal article
Source: PLoS One; v. 11, n. 1 JAN 4 2016.
Web of Science Citations: 6
Abstract

The development of a preventive vaccine against human immunodeficiency virus (HIV-1) infection is the most efficient method to control the epidemic. The ultimate goal is to develop a vaccine able to induce specific neutralizing, non-neutralizing antibodies and cellular mediated immunity (CMI). Humoral and CMI responses can be directed to glycoproteins that are normally presented as a trimeric spike on the virus surface (gp140). Despite safer, subunit vaccines are normally less immunogenic/effective and need to be delivered together with an adjuvant. The choice of a suitable adjuvant can induce effective humoral and CMI that utterly lead to full protection against disease. In this report, we established a hierarchy of adjuvant potency on humoral and CMI when admixed with the recombinant HIV gp140 trimer. We show that vaccination with gp140 in the presence of different adjuvants can induce high-affinity antibodies, follicular helper T cells and germinal center B cells. The data show that poly (I:C) is the most potent adjuvant to induce specific CMI responses evidenced by IFN-gamma production and CD4(+)/CD8(+) T cell proliferation. Furthermore, we demonstrate that combining some adjuvants like MPL plus Alum and MPL plus MDP exert additive effects that impact on the magnitude and quality of humoral responses while mixing MDP with poly (I:C) or with R848 had no impact on total IgG titers but highly impact IgG subclass. In addition, heterologous DNA prime-protein boost yielded higher IgG titers when compare to DNA alone and improved the quality of humoral response when compare to protein immunization as evidenced by IgG1/IgG2a ratio. The results presented in this paper highlight the importance of selecting the correct adjuvant-antigen combination to potentiate desired cells for optimal stimulation. (AU)

FAPESP's process: 11/10154-0 - Influence of preimmunization with a vaccine encoding HIV CD4+ T cell epitopes on the immune response against Env in the presence of different adjuvant formulations
Grantee:Daniela Santoro Rosa
Support Opportunities: Regular Research Grants